Published • loading... • Updated
Study Combines Semaglutide (Ozempic and Wegovy) with the Reduction of Biological Aging of Organs
Research published in Nature Communications shows that the drug can slow down epigenetic aging in multiple systems of the body, including brain, heart, liver and kidneys A new study published in Nature Communications has associated the use of semaglutide — the active principle of medicines such as Ozempic and Wegovy — with a reduction in the biological age of [...]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Research published in Nature Communications shows that the drug can slow down epigenetic aging in multiple systems of the body, including brain, heart, liver and kidneys A new study published in Nature Communications has associated the use of semaglutide — the active principle of medicines such as Ozempic and Wegovy — with a reduction in the biological age of [...]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
